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Palliation of malignant small intestinal obstructions beyond the reach of conventional endoscopes for stent placement generally requires endoscopic
decompression via a gastrostomy tube or a surgical bypass in patients who are operable candidates. With the advent of deep enteroscopy, palliative stent
placement for mid-gut obstruction using currently available self-expandable metal stents may be feasible in selected cases. Proper patient selection and
technical proﬁciency in deep enteroscopy and stent placement are key determinants for a successful outcome. Alternative means of stent delivery,
including the percutaneous route, are also being developed, with the hope of expanding the use of stents in the mid small bowel beyond palliation.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier.
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Placement of a self-expandable metal stent (SEMS) is an
accepted therapeutic option for palliation of malignant obstruction
involving the esophagus, gastroduodenum, and colon, and dedi-
cated SEMS are available for over-the-wire or through-the-scope
(TTS) insertion across obstructive lesions at these locations.1,2 Ma-
lignant small bowel obstruction is a dire complication of intrinsic
disease or extrinsic compression from abdominopelvic tumors.
However, endoscopic stent placement in the mid small bowel,
deﬁned as the segment between the ampulla of Vater and the
ileocecal valve, can be technically challenging or infeasible owing to
the anatomy of the small intestine, limitations of conventional
endoscopes, and lack of TTS SEMS designed speciﬁcally for use in
the mid gut.3
Palliation of malignant obstruction in the distal duodenum, and
even the proximal jejunum, can generally be achieved using a
therapeutic upper endoscope or an adult colonoscope whose large
working channel can accommodate TTS placement of currently
available enteral SEMS.4 In some cases, however, signiﬁcant looping
in the stomach and duodenal sweep limits endoscope insertion to
more distal areas of obstruction and palliative surgical intervention,
such as a bypass or diverting ostomy, is necessary. In poor surgical
candidates, placement of a venting percutaneous endoscopic gas-
trostomy (PEG) or jejunostomy tube may be required.5,6
The introduction of double balloon enteroscopy (DBE) and,
subsequently, single balloon enteroscopy and spiral overtube-
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These techniques, collectively referred to as deep enteroscopy,
can overcome looping, such as in a J-shaped stomach, and enable
access to deeper segments of the small intestine for palliative stent
placement. Balloon-assisted enteroscopy involves sequential push–
pull maneuvers, whereas SE uses rotation of a specialized overtube
with raised spirals at its tip to pleat the small bowel onto the
overtube and enable enteroscope insertion deep into the small
bowel.9 Although the working channel of deep enteroscopes
(2.8 mm diameter) does not allow TTS passage of currently avail-
able SEMS and there are no dedicated stents for enteroscopic use,
the deep enteroscopy techniques provide a stable platform via a
ﬁxed overtube for the non-TTS delivery of stents to the mid gut, as
outlined below.
Indications and practical considerations
Although the major indication for mid-gut stent placement is
palliation of malignant extrinsic or intrinsic obstructions, other po-
tential indications includepreoperative decompression as a bridge to
surgery, closure of malignant chronic ﬁstulae, and sealing of anas-
tomotic leaks for which surgical revision is deemed too risky.3
Careful patient assessment remains an absolute prerequisite
prior to considering stent placement for palliation of mid-gut ste-
nosis. Radiological imaging, such as computed tomography of the
abdomen and pelvis, is essential and may demonstrate multifocal
sites of small bowel obstruction, which negate the beneﬁt of
placing a stent at a single point of obstruction (Fig. 1). This is0 1st Street South West, Rochester, MN 55905, USA.
vier. Open access under CC BY-NC-ND license.
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tosis, where a venting PEG may be the best palliative option. Im-
aging is not foolproof, however, and distal sites of obstruction may
manifest themselves only after stent placement for a radiographi-
cally apparent isolated proximal stenotic segment has been
performed.
The use of an adult colonoscope can be effective in delivering
enteral stents for malignant obstructions of the distal duodenum
and proximal jejunum, and should be given primary consideration
for lesions at these locations. The technical success rate was 93% in
one study of 16 patients with malignant distal duodenal or prox-
imal jejunal obstruction.4 Of note, nine of the patients had under-
gone prior unsuccessful attempts at stent placement using a
gastroscope.
Surgical bypass should be considered preferentially for patients
with a reasonable performance status and a longer life expectancy,
as it is associated with better long-term outcomes, fewer adverse
events, and a lesser rate of intervention relative to stent place-
ment.5,10 Although the data pertain primarily to gastric outlet
obstruction, the ﬁndings can likely be extrapolated to malignant
mid-gut obstruction.
Deep enteroscopy for stent placement in the mid gut
Although the depth of insertion and rate of complete entero-
scopy is greater with DBE, clinical comparative trials have shown
similar diagnostic and therapeutic yields among the deep entero-
scopy instruments.8,11 All three modalities appear to be equally safe
and effective for the evaluation of the small intestine. Thus, the
selection of a particular device is inﬂuenced primarily by device
availability and operator preference.
A deep enteroscopy approach for the palliative stenting of mid-
gut obstructions represents an attractive option over surgicalFig. 1. Multifocal areas of obstruction with dilation and fecalization of the small bowel
due to extensive peritoneal carcinomatosis.intervention because of its minimally invasive nature and expected
lower rate of procedure-related morbidity, particularly in termi-
nally ill patients with a poor performance status. Deep enteroscopy,
however, may not be suitable or feasible in patients with bowel
encasement from widespread peritoneal carcinomatosis and in
those with severe small bowel ﬁxation and angulation from sur-
gical adhesions that hinder advancement of the enteroscope.
Therefore, the decision to proceed with deep enteroscopy-assisted
stent placement for palliating mid gut obstruction should be indi-
vidualized. Two methods of mid-gut stent insertion using deep
enteroscopy instruments and commercially available SEMS have
been described: the withdrawal–reinsertion technique and the
through-the-overtube technique.
Withdrawal–reinsertion technique
Lee et al12 described the use of the withdrawal–reinsertion
technique that involves the advancement of DBE and balloon-
assisted reduction maneuvers, as needed, to reach the site of
obstruction, the insertion of a long guide-wire through the stric-
ture, and instrument removal while leaving the guide-wire in place.
The guide-wire is then back-fed into the working channel of a
conventional therapeutic endoscope, which is advanced as far as
technically feasible into the gut lumen. A TTS SEMS is subsequently
inserted over the guide-wire and placed across the stricture, fol-
lowed by stent deployment under both endoscopic and ﬂuoro-
scopic view. The length of the selected stent is based on the
estimated length of the stricture at endoscopy or following ﬂuo-
roscopic contrast assessment.
In the series by Lee et al,12 19 patients underwent the with-
drawal–reinsertion technique as a rescue procedure for failed
conventional palliative stent placement for malignant small bowel
obstruction. Small intestinal obstruction was due to metastatic
gastric (n ¼ 15), colorectal (n ¼ 2), and primary small bowel cancer
(n ¼ 2), and the obstruction sites were in the efferent jejunal limb
(53%), proximal jejunum (32%), or third portion of the duodenum
(15%). The technical success rate was 95%, and the clinical success
rate, deﬁned as relief of obstructive symptoms after stent place-
ment, was 84%. No major procedure-related adverse events
occurred. Stent migration and restenosis occurred in 11% and 21% of
patients, respectively, with median stent patency duration of 67
days.12 Potential drawbacks of this technique include the risk of
losing the guide-wire with the unfolding of small bowel pleats
during the removal of the deep enteroscope or during the insertion
of the second endoscope, as well as looping of the conventional
endoscope in the stomach despite its advancement over the guide-
wire. This technique may be more suited for proximally situated
small bowel lesions, but not likely to succeed for obstructing lesions
located in the mid-distal jejunum and beyond.
Through-the-overtube technique
The through-the-overtube technique for placement of stents in
the mid gut has been described for all three deep enteroscopy in-
struments. Data regarding this technique are currently limited to
case reports and small series (Table 1).13–20
The technique involves the use of the dedicated balloon-assisted
or spiral overtubes as conduits for placement of esophageal or
enteral SEMS through malignant mid-gut obstruction under ﬂuo-
roscopic guidance (Fig. 2). The procedure is relatively similar for all
three enteroscopic systems, albeit with technical nuances to
compensate for length discordance between overtubes and stent
delivery catheters.
In brief, a deep enteroscope with balloon-assisted or spiral
overtube is advanced to the stricture site. With the tip of the
Table 1 Deep Enteroscopy Overtube-Assisted Stent Placement for Malignant Small Bowel Obstruction
Study N Location of malignant obstruction Stent Endoscope Route of insertion Clinical success* AE
Yamamoto et al 200413 2 NR Esophageal
Ultraﬂex
DBE NR NR No
Ross et al 200615 1 Distal duodenum Esophageal
Ultraﬂex
DBE Oral Yes No
Kita et al 200714 6 NR NR DBE Oral/Anal NR NR
Pérez-Cuadrado et al 201318 1 Distal jejunum Enteral
Taewoong Niti-S
DBE Oral Yes No
Popa et al 201417 1 Proximal jejunum Enteral
Wallﬂex
DBE Oral Yes No
Espinel and Pinedo 201119 1 Distal duodenum Enteral
Wallﬂex
SBE Oral Yes No
Lennon et al 201020 2 Proximal jejunum Enteral
Wallﬂex
SE Oral Yes No
AE, adverse events; DBE, double balloon enteroscope, NR, not reported; SBE, single balloon enteroscope; SE, spiral enteroscope.
* Deﬁned as ability to tolerate at least a liquid diet.
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vers are performed to reduce loop formation proximal to the ste-
notic site and to maintain an overtube conﬁguration in the
straightest and shortest path possible to facilitate passage of the
stent’s delivery catheters, which are relatively stiff and inﬂexible.
Although SE has a lower insertion depth than DBE, it may provide
better anchoring and a more stable platform than balloon over-
tubes, which can slip.20
Once in position at the obstruction site, the length of the stric-
ture can be assessed endoscopically or by ﬂuoroscopic contrast
instillation if the enteroscope cannot traverse the stricture. A
ﬂuoroscopic marker (endoscopic clip or intramural contrast injec-
tion) can be placed to identify the proximal and/or distal end (if
traversed) of the stricture. Thereafter, a long guide-wire is
advanced as far as feasible beyond the stricture, followed byFig. 2. Schematic layout of mid-gut stent placement using double balloon enteroscopy. (A)
(B) Guide-wire advancement beyond the obstruction. (C) Enteroscope removal leaving over
the stent’s delivery system across the obstruction. (E) Stent deployment under ﬂuoroscopicwithdrawal of the enteroscope while leaving the guide-wire and
overtube in place. For DBE, withdrawal of the enteroscope through
its overtube can be problematic and may result in loss of the
overtube position owing to the traction force required to disrupt
the manufacturer’s rubber band used to afﬁx the enteroscope’s
balloon at its tip. As an alternative, the enteroscope’s balloon can be
afﬁxed with a suture instead of the rubber band, enabling the
retraction of the enteroscope into the overtube while preserving
the double-balloon maneuvers unique to DBE (Fig. 3). Another
caveat is that the stent’s delivery catheter (e.g., esophageal SEMS)
may not be long enough to pass through the entire length of the
overtube, in addition to the stricture site. One solution is tomake an
incision with a scalpel through the lining of the overtube close to
the mouth and transfer the guide-wire so it exits through the
incision site. Of note, caution is warranted to make the incisionInstrument advancement to the site of obstruction with balloon anchoring of overtube.
tube and guide-wire in place. (D) Through-the-overtube and over-the-wire insertion of
view.
Fig. 3. Modiﬁcation of balloon ﬁxation at the tip of the endoscope. (A) Replacement of the standard rubber band with silk suture to afﬁx the balloon at the tip of the endoscope. (B)
This allows retraction of the balloon-loaded enteroscope through the overtube and (C) preserves the double balloon maneuvers unique to double balloon enteroscopy.
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overtube balloon. This maneuver can signiﬁcantly truncate the
distance from the mouth to the obstruction site and enable the
selection of a shorter stent delivery system to reach its target
(Fig. 4). Another alternative is to use the short DBE instrument, if
available, which has an overtube length of 105 cm as opposed to
145 cm for the standard DBE overtube.18
Under ﬂuoroscopic view, the selected stent’s delivery catheter is
advanced over the guide-wire and through the overtube for
placement across the stricture. To avoid inadvertent deployment of
the proximal ﬂange of the stent in the overtube, distal-release
esophageal or enteral SEMS is used and partially deployed. The
overtube is subsequently retracted at a safe distance from the
proximal aspect of the stricture and the stent is then completely
released.
After stent deployment, the enteroscope can be reintroduced
through the overtube to conﬁrm satisfactory positioning (Fig. 5).
Contrast ﬂush can also be administered to conﬁrm free ﬂow and
patency of the stent.
Alternative methods for stent placement in the mid gut
Oral or rectal routes of endoscopic stent delivery in the mid gut
are not always feasible, particularly in the setting of altered gut
anatomy. Percutaneous insertion of enteral SEMS in themid gut has
been described in such cases, usually after a failed endoscopic
attempt at stent placement. Percutaneous routes utilized for enteral
SEMS placement have included percutaneous endoscopic duode-
nostomy, percutaneous tube enterostomy, and percutaneous
transhepatic cholangiostomy. In a review by Zhang et al,3 an esti-
mated 10.5% and 9.3% of enteral stents were deployed using
percutaneous endoscopic duodenostomy/percutaneous tube en-
terostomy and percutaneous transhepatic cholangiostomy,
respectively. The major indication for percutaneous placement ofFig. 4. Technique for passage of shorter length stent’s delivery catheter through overtube o
scalpel. (B) Transfer of the guide-wire (arrow) so it exits through the incision site. (C) Sho
(rather than the proximal end of the overtube) to the obstruction site.an enteral stent was for palliation of malignant obstructions in
patients with surgically altered gut anatomy, particularly at an
afferent loop.
Other radiological interventions include percutaneous radio-
logical jejunostomy long tube placement following jejunopexy to
decompress the small bowel proximal to the obstruction and to
provide a route via the percutaneous radiological jejunostomy for
subsequent SEMS placement to palliate one or more small bowel
obstructions. In one study, clinical success using this technique was
achieved in 18 of 21 patients (85.7%), although major (peritonitis)
and minor procedure-related adverse events occurred in 4.8% and
28.6% of patients, respectively.21
Percutaneous stent placement requires a matured ﬁstulized
tract, a process that typically takes 1 month on average. This delay
is not suitable for acutely ill patients. Furthermore, endoscope
passage through the percutaneous tract is limited by the diameter
of the tract, greatly restricting the size of endoscopes that can be
used. To circumvent the need for a matured tract and subsequent
delay in stenting, a percutaneous assisted transprosthetic endo-
scopic therapy (PATENT) procedure has been proposed, whereby a
covered SEMS is deployed through a freshly created enter-
ocutaneous tract secured by T-tags.22 The secured expansion of the
tract with the SEMS allows a one-step transprosthetic procedure
and the possibility for repeated interventions using therapeutic
endoscopes. The PATENT procedure has been described in proof-
of-concept studies, including single-session antegrade endo-
scopic retrograde cholangiopancreatography (ERCP) through a
fresh PEG tract in patients with a Roux-en-Y gastric bypass,23
drainage of the gallbladder through an SEMS-secured chol-
ecystostomy tract,24 and transprosthetic access through a PEG
tract to control a bleeding ulcer at a gastrojejunal anastomosis
using a standard upper endoscope.25 The PATENT technique may
not only be applicable for palliation of malignant mid-gut
obstruction, but also for a variety of benign small intestinalf double balloon endoscope. (A) Incision through overtube close to the mouth using a
rtened over-the-wire travel distance for the stent’s delivery catheter from the mouth
Fig. 5. Mid gut stent placement via single balloon enteroscopy. (A) Malignant mid jejunal obstruction with proximal bowel dilation on computed tomography. (B) Advancement of
single balloon enteroscope to the site of obstruction. (C) Enteroscopic and ﬂuoroscopic conﬁrmation of satisfactory stent deployment across the obstruction.
Gastrointestinal Intervention 2014 3(1), 30–3434conditions, including placement of biodegradable or drug-eluting
stents to manage Crohn’s strictures not accessible by standard
endoscopes.
Future directions
Deep enteroscopic stent placement for malignant mid-gut
obstruction beyond the reach of conventional endoscopes is an
appealing option in patients who are deemed poor surgical can-
didates. Relative to surgery, stent placement allows for amore rapid
return to functional bowel status, with shorter hospital stay and a
lower rate of early adverse events. However, stent insertion deep in
the mid gut is a technically challenging and complex procedure,
requiring the inventive use of currently available deep enteroscopy
instruments and SEMS not speciﬁcally suited for that purpose. Stent
placement for deep small bowel obstruction represents the last
frontier for gastrointestinal endoscopic stenting. The development
of new enteroscopes that allow TTS stent placement and/or novel
highly ﬂexible stent designs compatible with current enteroscopes
will facilitate endoscopic stenting of the mid gut, with the appli-
cation extending beyond palliation in the foreseeable future.26
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